Stockholders' Equity (Details) - USD ($)					1 Months Ended	3 Months Ended		6 Months Ended	9 Months Ended	12 Months Ended
	Mar. 09, 2021	Feb. 11, 2021	Apr. 02, 2020	Feb. 11, 2020	Oct. 18, 2021	Jun. 30, 2022	Dec. 31, 2021	Jun. 30, 2022	Sep. 30, 2020	Dec. 31, 2021	Jun. 24, 2022	Dec. 08, 2021
Stockholders' Equity (Details) [Line Items]
Common stock share authorized						100,000,000	100,000,000	100,000,000		100,000,000
Common stock share issued						46,623,618	46,450,250	46,623,618		46,450,250
Preferred shares authorized						10,000,000	10,000,000	10,000,000		10,000,000
Common shares issued for conversion of preferred stock										7,500,000
Price per share (in Dollars per share)						$ 0.01	$ 0.01	$ 0.01		$ 0.01
Sole consideration of shares issued			2,028,208
ATM agreement				the Company entered into an ATM Agreement with Wainwright, which was amended and restated on November 13, 2020 to add BTIG, LLC as a sales agent, pursuant to which the Company could offer and sell from time to time in an “at the market offering,” at its option, up to an aggregate of $22.1 million of shares of the Company's common stock through the sales agents. During the year ended December 31, 2021, the Company sold 680,000 shares of its common stock under the 2020 ATM Offering resulting in aggregate net proceeds to the Company of approximately $1.48 million, and gross proceeds of $1.55 million. The Company terminated the ATM Agreement in June 2022 in conjunction with the execution of the 2022 ATM Agreement.
Common stock share outstanding						46,623,618	46,450,250	46,623,618		46,450,250
Before Amendment [Member] | Common Stock [Member]
Stockholders' Equity (Details) [Line Items]
Common stock share authorized												50,000,000
After Amendment [Member] | Common Stock [Member]
Stockholders' Equity (Details) [Line Items]
Common stock share authorized												100,000,000
2015 Plan [Member]
Stockholders' Equity (Details) [Line Items]
Authorized issuance share						2,710		2,710
Stock option description								In addition, the number of shares that have been authorized for issuance under the 2015 Plan will be automatically increased on the first day of each fiscal year beginning on January 1, 2016 and ending on (and including) January 1, 2025, in an amount equal to the lesser of (1) 4% of the outstanding shares of common stock on the last day of the immediately preceding fiscal year, or (2) another lesser amount determined by the Company’s Board of Directors.
Shares added						1,858,010		1,858,010
Remaining shares						1,284,296		1,284,296
First Annual Anniversary [Member]
Stockholders' Equity (Details) [Line Items]
Vesting percentage for three years								25.00%
Vesting percentage per quarter,								6.25%
Holder pursuant to company issued to Holder securities [Member] | New Warrants [Member]
Stockholders' Equity (Details) [Line Items]
Exercise price (in Dollars per share)	$ 3.56
Purchase of share warrant	0.65
Warrants purchase	3,147,700
Aggregate purchase of warrants (in Dollars)	$ 255,751
Holder pursuant to company issued to Holder securities [Member] | Warrants [Member]
Stockholders' Equity (Details) [Line Items]
Gross proceeds before expenses (in Dollars)	9,650,000
Non-cash warrant inducement expense (in Dollars)	$ 7,800,000
October 2021 Offering [Member] | Common Stock [Member]
Stockholders' Equity (Details) [Line Items]
Net proceeds (in Dollars)										$ 13,900,000
Gross proceeds (in Dollars)							$ 15,000,000			$ 15,000,000
October 2021 Offering [Member] | Healthcare-focused Institutional Investor [Member]
Stockholders' Equity (Details) [Line Items]
Share issued					150,000
Exercise price (in Dollars per share)					$ 2.05
Shares issued for unregistered common warrants to purchase common stock		4,166,666
Price per share (in Dollars per share)					$ 100
Aggregate share					7,500,000		7,500,000			7,500,000
October 2021 Offering [Member] | Healthcare-focused Institutional Investor [Member] | Pre Funded Warrant [Member]
Stockholders' Equity (Details) [Line Items]
Share issued					7,500,000
Preferred stock, per share (in Dollars per share)					$ 100
Aggregate conversion of common stock					7,500,000
Conversion price per share (in Dollars per share)					$ 2
October 2021 Offering [Member] | Healthcare-focused Institutional Investor [Member] | Warrants [Member]
Stockholders' Equity (Details) [Line Items]
Share issued					7,500,000
October 2021 Offering [Member] | Investor [Member]
Stockholders' Equity (Details) [Line Items]
Exercise price (in Dollars per share)					$ 2.05
Preferred stock deemed dividend (in Dollars)							$ 7,166,752
2020 PIPE [Member] | Healthcare-focused U.S. Institutional Investor [Member]
Stockholders' Equity (Details) [Line Items]
March 2021 Warrant Exercise Agreement	4,842,615
February 2021 Offering [Member]
Stockholders' Equity (Details) [Line Items]
Exercise price (in Dollars per share)		$ 3.55
February 2021 Offering [Member] | Healthcare-focused Institutional Investor [Member]
Stockholders' Equity (Details) [Line Items]
Share issued		2,784,184
Exercise price (in Dollars per share)		$ 0.01
Price per share (in Dollars per share)		$ 3
Aggregate share		2.99
Net proceeds (in Dollars)		$ 23,500,000
Gross proceeds (in Dollars)		$ 25,000,000
February 2021 Offering [Member] | Healthcare-focused Institutional Investor [Member] | Pre Funded Warrant [Member]
Stockholders' Equity (Details) [Line Items]
Share issued		5,549,149								5,549,149
February 2021 Offering [Member] | Healthcare-focused Institutional Investor [Member] | Warrants [Member]
Stockholders' Equity (Details) [Line Items]
Share issued		5,549,149
February 2021 Offering [Member] | Investor [Member]
Stockholders' Equity (Details) [Line Items]
Exercise price (in Dollars per share)		$ 3.55
February 2021 Offering [Member] | Investor [Member] | Pre Funded Warrant [Member]
Stockholders' Equity (Details) [Line Items]
Exercise price (in Dollars per share)		$ 0.01
Stock options [Member]
Stockholders' Equity (Details) [Line Items]
Common stock share outstanding						2,215,755		2,215,755
Replacement Awards [Member]
Stockholders' Equity (Details) [Line Items]
Share options forfeited						7,691		10,191
Share options expired						28,367		29,903
Share options granted								542,500
Replacement Awards [Member] | 2016 Stock Option Plan [Member]
Stockholders' Equity (Details) [Line Items]
Stock options								134,371
Weighted average grant date fair value (in Dollars per share)								$ 1.68
Restricted stock units [Member]
Stockholders' Equity (Details) [Line Items]
Stock units granted						60,000		730,572
Stock units vested						65,868		173,368
Stock units forfeited						7,826		10,402
Stock units outstanding								833,066
Executive Officers And Non-Employee Directors [Member] | 2020 Stock Options Plan [Member]
Stockholders' Equity (Details) [Line Items]
Common stock share authorized									1,300,000
Share issued									1,300,000
Purchase of aggregate share									1,300,000
Chief Financial Officer [Member]
Stockholders' Equity (Details) [Line Items]
Exercise price (in Dollars per share)						$ 1.08		$ 1.08
Purchase of aggregate share								210,000
2020 ATM Offering [Member] | Common Stock [Member] | H.C. Wainwright & Co., LLC [Member]
Stockholders' Equity (Details) [Line Items]
Aggregate share (in Dollars)				$ 22,100,000
Share issued										680,000
2020 ATM Offering [Member] | Common Stock [Member] | H.C. Wainwright & Co., LLC [Member] | Minimum [Member]
Stockholders' Equity (Details) [Line Items]
Aggregate share (in Dollars)											$ 10,650,000
2020 ATM Offering [Member] | Common Stock [Member] | H.C. Wainwright & Co., LLC [Member] | Maximum [Member]
Stockholders' Equity (Details) [Line Items]
Aggregate share (in Dollars)							$ 150,000			$ 150,000